داروسازی لقمان
دلقما | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 9,900 2.06
Close Price: 9,720
Income Statement
AGM
Interim
2026/07/12 Fiscal Year 2026/03/2012 Month | 2025/07/19 Fiscal Year 2025/03/2012 Month | 2024/07/21 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 23.468 Trillion | 11.605 Trillion | 9.836 Trillion | |
Total Revenues | 23.468 Trillion | 11.605 Trillion | 9.836 Trillion | |
Cost of Goods Sold | 14.998 Trillion | 9.08 Trillion | 7.92 Trillion | |
Gross Profit | 8.47 Trillion | 2.525 Trillion | 1.916 Trillion | |
General & Administrative Expenses | 1.203 Trillion | 707.931 Billion | 499.042 Billion | |
Net Operating Income & Expenses | -42.674 Billion | -242.27 Billion | 5.307 Billion | |
Operating Profit (Loss) | 7.224 Trillion | 1.575 Trillion | 1.422 Trillion | |
Profit Before Tax | 7.488 Trillion | 1.078 Trillion | 1.069 Trillion | |
Tax | 996.053 Billion | 225.8 Billion | 236.519 Billion | |
Net Profit (Loss) After Tax | 6.474 Trillion | 852.012 Billion | 832.814 Billion | |
Retained Earnings at Beginning of Period | 4.34 Trillion | 4.036 Trillion | 4.053 Trillion | |
Prior-Year Tax | 18.769 Billion | - | - | |
Approved Dividends — Prior Year AGM | -767.807 Billion | -505.136 Billion | -808.218 Billion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | -3.5 Trillion | - | - | |
Allocable Profit | 6.546 Trillion | 4.383 Trillion | 4.078 Trillion | |
Legal Reserve | 323.682 Billion | 42.601 Billion | 41.641 Billion | |
Approved Dividends — Current Year | 3.234 Trillion | 767.807 Billion | 505.136 Billion | |
Retained Earnings at End of Period | 2.988 Trillion | 3.573 Trillion | 3.531 Trillion |